Influenza: Prospects for control

被引:27
作者
Couch, RB [1 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.7326/0003-4819-133-12-200012190-00015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Influenza is a disease of antiquity that annually imposes a major burden of morbidity and mortality. The available inactivated vaccine is effective for preventing influenza and the serious disease and death that can accompany it. However, annual recommendations for vaccination among persons at risk have never been adequately implemented. This remains the most pressing current need for control of influenza. Amantadine, rimantadine, and the newly available drugs zanamivir and oseltamivir are effective for influenza prevention and treatment (the former two for influenza A only). The availability of four antiviral agents that effectively prevent and treat influenza provides the physician with considerable flexibility for their use in influenza control. Optimal application of the currently available vaccine and antiviral agents should substantially reduce the impact of influenza. Other methods for influenza treatment and control are under development, and a live attenuated vaccine with substantial potential for control is nearing approval. However, better inactivated vaccines, better rapid diagnostic tests, and an increased understanding of options for use of antiviral agents are still needed. When all of these things are available and optimally applied, effective control of influenza should result. The prospect is compelling. Full participation by the practicing physician will be necessary to achieve this goal.
引用
收藏
页码:992 / 998
页数:7
相关论文
共 37 条
[1]   AN ANALYSIS OF EFFECTOR T-CELL GENERATION AND FUNCTION IN MICE EXPOSED TO INFLUENZA A OR SENDAI VIRUSES [J].
ADA, GL ;
LEUNG, KN ;
ERTL, H .
IMMUNOLOGICAL REVIEWS, 1981, 58 :5-24
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]   The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].
Belshe, RB ;
Mendelman, PM ;
Treanor, J ;
King, J ;
Gruber, WC ;
Piedra, P ;
Bernstein, DI ;
Hayden, FG ;
Kotloff, K ;
Zangwill, K ;
Iacuzio, D ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412
[4]   DOSE-RESPONSE OF A/ALASKA/6/77 (H3N2) COLD-ADAPTED REASSORTANT VACCINE VIRUS IN ADULT VOLUNTEERS - ROLE OF LOCAL ANTIBODY IN RESISTANCE TO INFECTION WITH VACCINE VIRUS [J].
CLEMENTS, ML ;
ODONNELL, S ;
LEVINE, MM ;
CHANOCK, RM ;
MURPHY, BR .
INFECTION AND IMMUNITY, 1983, 40 (03) :1044-1051
[5]   INFLUENZA - ITS CONTROL IN PERSONS AND POPULATIONS [J].
COUCH, RB ;
KASEL, JA ;
GLEZEN, WP ;
CATE, TR ;
SIX, HR ;
TABER, LH ;
FRANK, AL ;
GREENBERG, SB ;
ZAHRADNIK, JM ;
KEITEL, WA .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) :431-440
[6]  
COUCH RB, 1984, MOL VIROLOGY EPIDEMI, P119
[7]  
Couch Robert B., 1997, Journal of Infectious Diseases, V176, pS38, DOI 10.1086/514173
[8]  
Couch Robert B., 1997, P369
[9]   Prevention and early treatment of influenza in healthy adults [J].
Demicheli, V ;
Jefferson, T ;
Rivetti, D ;
Deeks, J .
VACCINE, 2000, 18 (11-12) :957-1030
[10]   A RANDOMIZED CONTROLLED TRIAL OF COLD-ADAPTED AND INACTIVATED VACCINES FOR THE PREVENTION OF INFLUENZA A DISEASE [J].
EDWARDS, KM ;
DUPONT, WD ;
WESTRICH, MK ;
PLUMMER, WD ;
PALMER, PS ;
WRIGHT, PF .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :68-76